Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Wednesday, February 26, 2020
The FDA is upgrading the Purple Book in phases with full search functionality for all approved biosimilar products and their reference products.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Tuesday, February 25, 2020
Sanofi plans to create a European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs).
read more
Tuesday, February 25, 2020
Levadura Biotechnology has received the ISR for Levadura’s first Patent Cooperation Treaty patent application.
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more
Friday, February 21, 2020
Sihuan announced Xuanzhu Biopharmaceutical acquired all interests and intellectual property rights of plazomicin.
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, including during public health emergencies.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Wednesday, February 05, 2020
CURE Pharmaceutical has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s pharmaceutical groups specialized in medicinal cannabis products.
read more
Tuesday, February 04, 2020
The FDA has posted laboratory results showing N- Nitrosodimethylamine (NDMA) levels in some metformin products approved in the U.S.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Tuesday, January 28, 2020
CNS announced Anthem Biosciences of Bangalore, India has completed a pilot run of the recrystallization of the Reata Pharmaceuticals API.
read more